Biomolecule Production

生物分子生产

• 批准号: 7645419
• 负责人: ROBIN A ROSS
• 金额: $ 35.2万
• 依托单位: HARVARD MEDICAL SCHOOL
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-03-01 至 2009-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7645419
• 关键词: Animals; Antigens; Arts; Biological Assay; Carbohydrates; Categories; Cells; Core Facility; Data; Doctor of Philosophy; Drug Formulations; Emerging Communicable Diseases; Eukaryotic Cell; Fermentation; In Vitro; Institution; Laboratories; Methods; New England; Paste substance; Plasmids; Preparation; Production; Proteins; Proteomics; Protocols documentation; Recombinant Proteins; Recombinants; Reporting; Research; Research Personnel; Robin bird; Running; Screening procedure; Services; System; Vaccines; Viral; biodefense; design; medical schools; scale up; small molecule

NERCE Core B: Biomolecule Production, Robin Ross, Ph.D., Harvard Medical School. As part of the New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (NERCE/BEID), the Biomolecule Production Core Laboratory provides services for production of medium to large scale amounts of purified bacterial, mammalian, and viral biomolecules to investigators conducting biodefense research. This core facility is a state-of-the-art laboratory designed to produce both recombinant proteins and native carbohydrate molecules for use in structural analyses and vaccine formulation. This includes, but is not restricted to, investigators in the following categories: those making use of the Proteomics and Small Molecule Screening Core Laboratories who need to produce sufficient quantities of identified proteins to accomplish proposed screens; those developing vaccines containing bacterial carbohydrate components who need large quantities of antigen for analysis in vitro biologic assays and animal studies; and those already expressing target proteins in small scale using recombinant systems who need larger amounts of recombinant protein to expand their research. Investigators provide data demonstrating efficacy of production and purification methods as well as strains or recombinant plasmid preparations where applicable. The laboratory scales-up these protocols for production and purification of 100's of mg of the target biomolecule that is delivered to the investigator with a report outlining the methods used. Since the Biomolecule Production Core opened in 2004, we have collaborated with 19 investigators from 8 research institutions and one company in the production of over 154 different biomolecules. We have conducted 339 fermentation runs for the production of biomolecules, generating 52 Kg of bacterial cells. More than 277 purifications have been completed and we have delivered to investigators 34 Kg of cell paste, 453 mg of purified carbohydrate, and 3.1 g of various purified recombinant protein

NERCE核心B：生物分子生产，Robin Ross博士，哈佛医学院。 作为新英格兰地区生物防御和新发传染病卓越中心的一部分， （NERCE/BEID），生物分子生产核心实验室提供培养基生产服务， 大量纯化的细菌、哺乳动物和病毒生物分子， 生物防御研究这个核心设施是一个最先进的实验室，旨在生产重组 蛋白质和天然碳水化合物分子用于结构分析和疫苗制剂。这 包括但不限于以下类别的调查人员： 蛋白质组学和小分子筛选核心实验室需要生产足够数量的 鉴定蛋白质以完成拟议的筛选;那些开发含有细菌的疫苗的人 碳水化合物组分，其需要大量抗原用于体外生物测定的分析， 动物研究;以及那些已经使用重组系统小规模表达靶蛋白的研究， 需要大量的重组蛋白来扩展他们的研究。研究者提供数据 证明生产和纯化方法以及菌株或重组质粒的功效 在适用的情况下进行准备。实验室扩大了这些方案，用于生产和纯化 100毫克的目标生物分子，交付给研究人员，并提供一份概述方法的报告 采用自2004年生物分子生产中心开放以来，我们已经与19名研究人员合作， 来自8家研究机构和一家公司的研究人员正在生产超过154种不同的生物分子。我们有 进行了339次发酵运行以生产生物分子，产生52 Kg细菌细胞。 已经完成了超过277次纯化，我们已经向研究人员交付了34公斤的细胞糊， 453 mg纯化碳水化合物和3.1 g各种纯化重组蛋白